Back to News
Market Impact: 0.3

Martin Zweig Detailed Fundamental Analysis

ISRGNDAQ
Company FundamentalsCorporate EarningsAnalyst InsightsInsider TransactionsHealthcare & BiotechInvestor Sentiment & Positioning
Martin Zweig Detailed Fundamental Analysis

Validea's guru fundamental report indicates Intuitive Surgical (ISRG) scores 77% using Martin Zweig's Growth Investor model, placing it just below the 80% threshold for strategic interest. While ISRG demonstrates strong current and historical EPS growth, favorable debt-to-equity, and positive insider transactions, the model flags its P/E ratio, sales growth rate, and earnings persistence as key weaknesses. This assessment suggests that despite its growth profile in the Medical Equipment & Supplies sector, valuation and sales momentum are concerns under this specific growth-oriented framework.

Analysis

Intuitive Surgical (ISRG) receives a moderately positive but ultimately cautionary assessment under Validea's Martin Zweig-based Growth Investor model, scoring 77%, which is just shy of the 80% threshold indicating strategic interest. The analysis reveals a company with a strong earnings profile, passing key tests for current quarter earnings, year-over-year quarterly earnings, and an accelerating EPS growth rate that outpaces both the prior three quarters and its historical average. Furthermore, ISRG meets the criteria for a low debt-to-equity ratio and positive insider transactions, suggesting balance sheet health and management confidence. However, the model flags critical weaknesses that temper the bullish earnings picture. ISRG fails on its P/E ratio, indicating a potentially stretched valuation, as well as on its sales growth rate and earnings persistence. This specific combination suggests that while bottom-line growth is currently robust and accelerating, it may not be fully supported by commensurate top-line momentum or a history of consistent, long-term earnings, presenting a classic growth-at-a-high-price dilemma for investors.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo